Clinical Trials Logo

Clinical Trial Summary

This is an open-label dose-escalating study to evaluate the tolerability and systemic exposure of MDT-10013 in men and women at least 18 years of age who are undergoing primary unilateral TKA.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02263222
Study type Interventional
Source Medtronic Spinal and Biologics
Contact
Status Withdrawn
Phase Phase 2
Start date February 2016
Completion date June 2016